Pursuant to section 6001 of the Families First Coronavirus Response Act (the "FFCRA") as amended by Sections 3201 and 3202 of the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") specifically as the foregoing relate to the provision and reimbursement of orders for and or administration of SARS-CoV-2 or COVID-19 (collectively, "COVID-19) in vitro diagnostic tests (including serological tests used to detect COVID-19 antibodies) as well as the provision and reimbursement of items and services furnished to individuals during visits that result in an order for, or administration of a COVID-19 in vitro diagnostic tests) and or the provision and reimbursement of services related to the evaluation of such individuals by the attending healthcare provider for purposes of determining the need for the product or service in question, the following are the lists by provider of PT codes and associated cash prices required by section 3202 (b) of the CARESAct related to the foregoing COVID-19 in vitro diagnostic testing services as well as said related items and services.Covid-19 (SARS-Cov-2) Rapid Antigen by nasopharyngeal swab - Cash Price: $350Molecular (PCR) Test - Cash Price: $450